A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates.
By S. Schrag, E. Zell, R. Lynfield, A. Roome, K. Arnold, A. Craig, L. Harrison, A. Reingold, K. Stefonek, Glenda Smith and 2 more. New England Journal of Medicine, 2002
605 citations recorded by the source corpus.
Subfields: Epidemiology, Microbiology, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/c75e8b1f44784282aa8b7f32c01383427bfe3275
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Public Health, Environmental and Occupational Health
Citations in the corpus
- Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. (2008, background): “32 per 1000 live births.(24) Our analysis indicates that incidence of early onset disease in the years following the guidelines decreased to 0.”
- Antenatal care : routine care for the healthy pregnant woman (2008, background): “…from children under three months of age Incidence of GBS Neonatal infection 1.42/1000 live births (95% CI 0.8 to 2.04) CSS 3 Evidence tables 223 Schrag et al., 2002 443 A stratified random sample of 5144 live births were selected from 629,912 live births from 1998 and 1999 from 8 geographical…”
- Early Onset Neonatal Sepsis: The Burden of Group B Streptococcal and E. coli Disease Continues (2011, neutral): “003) Thrombocytopeniae 77 (22) 9 (21) 34 (40) 10 (11) 7 (37) 19 (15) 41 (40) .”
- Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. (2010, background): “Subsequent observational studies have found the effectiveness to be 86%–89% among infants born to women who received intrapartum GBS prophylaxis (62,68).”